Nasdaq-listed biotech firm Sonnet BioTherapeutics announced Monday a $888 million merger agreement with Rorschach I LLC, an ...

Sonnet BioTherapeutics merges to launch Hyperliquid Strategies, holding $888M in HYPE tokens and cash to build a leading ...

Sonnet BioTherapeutics enters into an agreement to transform into the largest U.S.-based publicly listed company to hold HYPE ...

HYPE rallies toward $50 after Sonnet BioTherapeutics combines with Rorschach to launch a $583 million Hyperliquid token ...

Sonnet BioTherapeutics (NASDAQ:SONN) saw its stock soar by 290% after announcing an $888 million business combination that will pivot the company into a cryptocurrency treasury focused on HYPE tokens.

Hyperliquid (HYPE) trades near $48 on Monday following Sonnet BioTherapeutics' (SONN) announcement that it has entered a ...

Sonnet to merge with crypto-backed firm, forming Hyperliquid Strategies with $888 million in assets, plus HYPE blockchain ...

Sonnet BioTherapeutics will transform into a new entity called HyperLiquid Strategies at the agreement's close. The new company is expected to hold 12.6 million HYPE tokens and gross cash invested of ...

Sonnet BioTherapeutics pivots to crypto with $888M deal, forming Hyperliquid Strategies Inc. to hold 12.6M HYPE tokens.

DeFi Development is rolling out a global franchise for its Solana-based treasury model, betting that its structure will ...

Sonnet BioTherapeutics announced an $888 million business combination to create Hyperliquid Strategies Inc, a public ...

Combined company expected to become largest U.S.-based publicly listed company to hold HYPE in its treasuryPRINCETON, N.J., July 14, 2025 ( ...